Dan Dearborn
Chief Financial Officer · Kintara Therapeutics, Inc.
Individual
- 2024
- Jan 8, 2026
- 4
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Dan Dearborn's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- TC Group Cayman Investment Holdings, L.P. - $1.07B in MDLN purchases and sales in the last 12 months
- Martine A. Rothblatt - $798.23M in UTHR purchases and sales in the last 12 months
- TPG GP A, LLC - $742.97M in LFST purchases and sales in the last 12 months
- GTCR INVESTMENT XI LLC - $639.50M in SHC purchases and sales in the last 12 months
- Keith A. Meister - $591.13M in ILMN purchases and sales in the last 12 months
- Ronda E. Stryker - $580.89M in SYK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Dan Dearborn?
Dan Dearborn is a corporate insider, tracked as Chief Financial Officer of Kintara Therapeutics, Inc. (HURA). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Dan Dearborn last file a Form 4?
The most recent primary Form 4 on record is dated 8 January 2026, one of 4 filings going back to 2024.